Newly approved pancreatic cancer drug shows promise in lung cancer
Newly approved pancreatic cancer drug may extend survival for lung cancer patients.
3 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 3 separate news trends connected to Nejm, spanning July 13, 2026 through September 3, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 19 article observations and 19 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Newly approved pancreatic cancer drug may extend survival for lung cancer patients.
A personalized T-cell therapy has achieved complete remission in an adolescent patient suffering from metastatic kidney cancer.
Sana Biotechnology is advancing a hypoimmune-modified islet cell transplantation approach aiming for a functional cure for Type 1 diabetes.